Description: JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin, South Korea.
Home Page: www.jw-lifescience.co.kr
28, Hanjin 1-gil
Dangjin-si,
343-823
South Korea
Phone:
82 4 1351 7600
Officers
| Name | Title |
|---|---|
| Sungnam Cha | CEO & Director |
| Mr. Hyun-seok Han | Exec. Director & Product Plant Mang. |
| Jeong Yeol Noh | Exec. Director & Head of HP Research Center |
Exchange: KO
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.4314 |
| Price-to-Sales TTM: | 1.0486 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 259 |